The interventional oncology market is segmented into five major regions, namely North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe accounted for the second-largest share in 2018. The rising incidence of cancer, coupled with the growing geriatric population in Europe, is a key factor propelling the demand for interventional oncology products in this region. Prominent market players are focusing on improving the quality of patient care across Europe by commercializing advanced products, investing in technological innovations, and partnering with other institutions and organizations for spreading cancer awareness.
Interventional Oncology Market, by Product
Interventional Oncology Market, by Procedure
Interventional oncology Market, by Cancer Type
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly